The present study revealed that miR-937 could reduce HBE cells injury after CSE treatment via suppressing the TNF-α/IL-17 signaling pathway by targeting IL1B, indicating that miR-937 may have the potential to improve the therapeutic approaches of COPD. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.